This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lace, M. J.
Right arrow Articles by Haugen, T. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lace, M. J.
Right arrow Articles by Haugen, T. H.

 Previous Article  |  Next Article 

Journal of Virology, November 2008, p. 10841-10853, Vol. 82, No. 21
0022-538X/08/$08.00+0     doi:10.1128/JVI.01481-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

The E8{wedge}E2 Gene Product of Human Papillomavirus Type 16 Represses Early Transcription and Replication but Is Dispensable for Viral Plasmid Persistence in Keratinocytes{triangledown}

Michael J. Lace,1,2 James R. Anson,1 Gregory S. Thomas,2 Lubomir P. Turek,1,2 and Thomas H. Haugen1,2*

Department of Pathology, Veterans Affairs Medical Center,1 The University of Iowa Roy J. and Lucille A. Carver College of Medicine, Iowa City, Iowa 522422

Received 15 July 2008/ Accepted 15 August 2008

A conserved E8{wedge}E2 spliced mRNA is detected in keratinocytes transfected with human papillomavirus type 16 (HPV-16) plasmid DNA. Expression of HPV-16 E8{wedge}E2 (16-E8{wedge}E2) is independent of the major early promoter, P97, and is modulated by both specific splicing events and conserved cis elements in the upstream regulatory region in a manner that differs from transcriptional regulation of other early viral genes. Mutations that disrupt the predicted 16-E8{wedge}E2 message also increase initial HPV-16 plasmid amplification 8- to 15-fold and major early gene (P97) transcription 4- to 5-fold over those of the wild type (wt). Expressing the 16-E8{wedge}E2 gene product from the cytomegalovirus (CMV) promoter represses HPV-16 early gene transcription from P97 in a dose-dependent manner, as detected by RNase protection assays. When expressed from the CMV promoter, 16-E8{wedge}E2 also inhibits the amplification of an HPV-16 plasmid and a heterologous simian virus 40 (SV40) ori plasmid that contains E2 binding sites in cis. In contrast, cotransfections with HPV-16 wt genomes that express physiologic levels of 16-E8{wedge}E2 are sufficient to repress HPV-16 plasmid amplification but are limiting and insufficient for the repression of SV40 amplification. 16-E8{wedge}E2-dependent repression of HPV-16 E1 expression is sufficient to account for this observed inhibition of initial HPV-16 plasmid amplification. Unlike with other papillomaviruses, primary human keratinocytes immortalized by the HPV-16 E8 mutant genome contain more than eightfold-higher levels of unintegrated plasmid than the wt, demonstrating that 16-E8{wedge}E2 limits the viral copy number but is not required for plasmid persistence and maintenance.


* Corresponding author. Mailing address: Department of Pathology, The University of Iowa Roy J. and Lucille A. Carver College of Medicine, Iowa City, IA 52242. Phone: (319) 338-0581, ext. 5516. Fax: (319) 339-7178. E-mail: thomas-haugen{at}uiowa.edu

{triangledown} Published ahead of print on 27 August 2008.


Journal of Virology, November 2008, p. 10841-10853, Vol. 82, No. 21
0022-538X/08/$08.00+0     doi:10.1128/JVI.01481-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Lace, M. J., Anson, J. R., Klingelhutz, A. J., Lee, J. H., Bossler, A. D., Haugen, T. H., Turek, L. P. (2009). Human Papillomavirus (HPV) Type 18 Induces Extended Growth in Primary Human Cervical, Tonsillar, or Foreskin Keratinocytes More Effectively than Other High-Risk Mucosal HPVs. J. Virol. 83: 11784-11794 [Abstract] [Full Text]  
  • Lace, M. J., Yamakawa, Y., Ushikai, M., Anson, J. R., Haugen, T. H., Turek, L. P. (2009). Cellular factor YY1 downregulates the human papillomavirus 16 E6/E7 promoter, P97, in vivo and in vitro from a negative element overlapping the transcription-initiation site. J. Gen. Virol. 90: 2402-2412 [Abstract] [Full Text]  
  • Lace, M. J., Isacson, C., Anson, J. R., Lorincz, A. T., Wilczynski, S. P., Haugen, T. H., Turek, L. P. (2009). Upstream Regulatory Region Alterations Found in Human Papillomavirus Type 16 (HPV-16) Isolates from Cervical Carcinomas Increase Transcription, ori Function, and HPV Immortalization Capacity in Culture. J. Virol. 83: 7457-7466 [Abstract] [Full Text]  
  • Lace, M. J., Anson, J. R., Klingelhutz, A. J., Harada, H., Taniguchi, T., Bossler, A. D., Haugen, T. H., Turek, L. P. (2009). Interferon-beta treatment increases human papillomavirus early gene transcription and viral plasmid genome replication by activating interferon regulatory factor (IRF)-1. Carcinogenesis 30: 1336-1344 [Abstract] [Full Text]